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NF-κB activation is critical for 
bacterial lipoprotein tolerance-
enhanced bactericidal activity in 
macrophages during microbial 
infection
Jinghua Liu1,*, Jing Xiang1,*, Xue Li1, Siobhan Blankson2, Shuqi Zhao1, Junwei Cai1, 
Yong Jiang1, H. Paul Redmond2 & Jiang Huai Wang2
Tolerance to bacterial components represents an essential regulatory mechanism during bacterial 
infection. Bacterial lipoprotein (BLP)-induced tolerance confers protection against microbial sepsis 
by attenuating inflammatory responses and augmenting antimicrobial activity in innate phagocytes. 
It has been well-documented that BLP tolerance-attenuated proinflammatory cytokine production 
is associated with suppressed TLR2 signalling pathway; however, the underlying mechanism(s) 
involved in BLP tolerance-enhanced antimicrobial activity is unclear. Here we report that BLP-tolerised 
macrophages exhibited accelerated phagosome maturation and enhanced bactericidal activity upon 
bacterial infection, with upregulated expression of membrane-trafficking regulators and lysosomal 
enzymes. Notably, bacterial challenge resulted in a strong activation of NF-κB pathway in BLP-
tolerised macrophages. Importantly, activation of NF-κB pathway is critical for BLP tolerance-enhanced 
antimicrobial activity, as deactivation of NF-κB in BLP-tolerised macrophages impaired phagosome 
maturation and intracellular killing of the ingested bacteria. Finally, activation of NF-κB pathway in 
BLP-tolerised macrophages was dependent on NOD1 and NOD2 signalling, as knocking-down NOD1 
and NOD2 substantially inhibited bacteria-induced activation of NF-κB and overexpression of Rab10 
and Acp5, two membrane-trafficking regulators and lysosomal enzymes contributed to BLP tolerance-
enhanced bactericidal activity. These results indicate that activation of NF-κB pathway is essential for 
BLP tolerance-augmented antimicrobial activity in innate phagocytes and depends primarily on both 
NOD1 and NOD2.
A common and serious consequence of an overwhelming bacterial infection with the dysregulated systemic 
inflammatory response is the development of sepsis, septic shock, and their sequelae, which are the leading cause 
of death in intensive care units and the third cause of overall hospital mortality worldwide1–3. Despite significant 
achievements in our understanding of the molecular and genetic basis of sepsis and great advances in many 
areas of medicine over the last several decades, mortality rates of septic patients remain unacceptably high, rang-
ing from 30% to 70%4–6. Furthermore, the incidence of sepsis and its associated economic burden continues to 
increase steadily by 1% every year2,7. Currently, treatment of sepsis is limited largely to antibiotics, fluid resuscita-
tion, oxygen, and support of organ function, with no approved drugs that specifically target sepsis1,8.
The innate immune system responds rapidly through activation of pattern-recognition receptors (PRRs) 
upon detection of pathogen-associated molecular patterns (PAMPs), the highly conserved molecular struc-
tures of microbial pathogens and thus forms the first line of host defence against microbial infection9–11. The 
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transmembrane Toll-like receptors (TLRs), in particular TLR4 and TLR2, are the best known PRRs and play 
a key role in the host defence against gram-negative and gram-positive bacterial infection by activation of 
TLR-mediated intracellular signal transduction pathways and initiation of both inflammatory and antimicrobial 
responses in innate phagocytes including polymorphonuclear neutrophils (PMNs) and monocytes/macrophages, 
which ultimately culminate in eliminating the invading microbial pathogens9,11–13. Thus, TLRs function as innate 
sensors of pathogen attack and alert the body to the potential of bacterial infection. However, activation of TLRs 
is a double-edged sword14. Although normally helping to eradicate microbial pathogens from a local infection, 
a persistent activation of TLR-mediated signalling pathways in monocytes/macrophages, characterised by the 
excessive release of proinflammatory cytokines and chemokines, may lead to the development of septic shock 
syndrome. Therefore, activation of TLR signalling pathway-induced inflammatory responses must be tightly reg-
ulated and controlled during microbial infection.
Tolerance to bacterial cell wall components represents an essential regulatory mechanism during bacterial 
infection15,16. The TLR4 agonist, LPS- or endotoxin-induced tolerance is a well documented phenomenon where 
pre-exposure to a low dose of LPS induces a transient hyporesponsive state in monocytes/macrophages with 
reduced production of proinflammatory cytokines, thereby conferring protection against a subsequent ‘lethal’ 
LPS challenge and resulting in a significant survival advantage17,18. Although the primary function of LPS toler-
ance is to prevent an excessive inflammatory response induced by overactivation of the TLR4 signalling pathway, 
acquisition of LPS tolerance has been shown to correlate with an increased incidence of secondary bacterial 
infection in hospitalized patients due to development of an immunosuppressive state17,19. By contrast, tolerance 
induced by the gram-positive bacterial cell wall component bacterial lipoprotein (BLP), a TLR2 agonist, affords 
protection against not only a subsequent ‘lethal’ BLP challenge but also live Staphylococcus aureus (S. aureus) and 
Salmonella typhimurium (S. typhimurium) infection or cecal ligation and puncture (CLP)-induced polymicrobial 
sepsis20. Notably, BLP-induced tolerance also rescues TLR4-deficient mice from gram-negative S. typhimurium 
infection with a significant survival benefit21. This protection, afforded by BLP tolerance, against microbial sep-
sis is predominantly associated with BLP-induced reprogramming in innate phagocytes characterised by hypo-
responsiveness in producing proinflammatory cytokines and simultaneously, an enhanced antimicrobial activity 
including upregulated phagocytic receptor expression and enhanced bacterial ingestion and killing, with conse-
quently accelerated bacterial clearance from the circulation and visceral organs16,20,21.
It is well described that BLP tolerance-attenuated proinflammatory cytokine production is associated with the 
suppressed TLR2 signalling at both the upstream and downstream pathways including reduced TLR2 and IL-1 
receptor-associated kinase-1 (IRAK-1) expression, decreased myeloid differentiation factor 88 (MyD88)-IRAK 
immunocomplex formation, and inhibited NF-κ B activation and mitogen-activated protein kinase (MAPK) 
phosphorylation22–24. However, the underlying signal pathways and/or molecular events responsible for BLP 
tolerance-augmented antimicrobial activity have not been determined. In the current study, we report that 
BLP-tolerised macrophages displayed accelerated phagosome maturation and enhanced bactericidal activity in 
response to bacterial infection. Of note, bacterial stimulation led to a strong activation of the NF-κ B pathway in 
BLP-tolerised macrophages and this activation seems critical for BLP tolerance-augmented antimicrobial activ-
ity, as deactivation of NF-κ B in BLP-tolerised macrophages impaired phagosome maturation and intracellular 
bacterial killing. We further show that activation of the NF-κ B pathway by bacterial stimulation in BLP-tolerised 
macrophages appeared to be dependent on both NOD1 and NOD 2 signalling.
Results
BLP-tolerised macrophages show accelerated phagosome maturation and enhanced bac-
tericidal activity in response to bacterial infection. We first challenged naive and BLP-tolerised 
macrophages with gram-positive S. aureus and gram-negative S. typhimurium to examine the impact of BLP 
tolerisation on macrophage phagosome maturation and bactericidal activity. As shown in Fig. 1, BLP-tolerised 
macrophages displayed significantly enhanced uptake (p < 0.05, p < 0.01) (Fig. 1A) and phagocytosis (p < 0.05, 
p < 0.01) (Fig. 1B) of S. aureus and S. typhimurium compared with naive macrophages. Intracellular killing of the 
ingested S. aureus and S. typhimurium by BLP-tolerised macrophages was much higher than that observed in 
naïve macrophages (p < 0.05) (Fig. 1C).
A substantially accelerated phagosomal acidification after ingestion of S. aureus (p < 0.05) (Fig. 1D) or 
S. typhimurium (p < 0.01) (Fig. 1E) was observed in BLP-tolerised macrophages compared with naive mac-
rophages. Consistent with the accelerated phagosomal acidification, BLP-tolerised macrophages exhibited sig-
nificantly increased phagolysosome fusion at 30, 60, and 120 min after ingestion of S. aureus or S. typhimurium 
(p < 0.05 versus naive macrophages) (Fig. 1F) as determined in a cell-free organelle system.
We further loaded naive and BLP-tolerised macrophages with LysoTracker red that selectively labels late endo-
somes/lysosomes and monitored the maturation of phagosomes that have ingested S. aureus-FITC or E. coli-FITC 
by examining their ability to colocalise with LysoTracker red over time. A markedly increased colocalisation of 
either S. aureus-FITC (Fig. 1G) or E. coli-FITC (Fig. 1H) with LysoTraker red was observed in BLP-tolerised 
macrophages compared with naive macrophages. Collectively, these results indicate that in comparison with 
naive macrophages, BLP-tolerised macrophages are characterised with accelerated phagosome maturation and 
enhanced bactericidal activity in response to microbial infection.
BLP-tolerised macrophages display upregulated expression of membrane-trafficking reg-
ulators and lysosomal enzymes after bacterial infection. Upregulation and activation of 
membrane-trafficking regulators and lysosomal enzymes in innate phagocytes such as macrophages during the 
process of bacterial phagocytosis are critical events for subsequent phagosome/lysosome fusion and an efficient 
killing of the internalized pathogens within the phagocyte25–27. We next compared the gene expression profile of 
phagosome maturation-associated membrane-trafficking regulators and lysosomal enzymes between naive and 
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BLP-tolerised bone marrow-derived macrophages (BMMs). Among the 56 genes of membrane-trafficking regu-
lators and lysosomal enzymes analysed, 7 genes including Acp2, Acp5, Rab10, Rab20, Rabgef1, Camp, and Ctsc 
were upregulated in BLP-tolerised BMMs compared with naive BMMs (Supplementary Table 1).
To validate the above findings, we further assessed mRNA and protein expressing levels of these upregu-
lated genes and compared them between naive and BLP-tolerised BMMs. Significantly increased mRNA lev-
els of Acp2, Acp5, Rab10, Rab20, and Camp were observed in BLP-tolerised BMMs (p < 0.05, p < 0.01 versus 
naive BMMs) (Fig. 2A). Although Rabgef1 and Ctsc mRNA levels in BLP-tolerised BMMs were higher than 
those in naive BMMs, they did not reach statistical significances (Fig. 2A). Western blot analysis further revealed 
that BLP-tolerised BMMs displayed upregulated protein expression of both Rab10 and Acp5 over naive BMMs 
before bacterial challenge (Fig. 2B), while S. typhimurium infection led to further increases in Rab10 and Acp5 
protein expression in BLP-tolerised BMMs compared with naive BMMs (Fig. 2B). These results indicate that 
BLP-tolerised macrophages are featured with upregulation of membrane-trafficking regulators and lysosomal 
enzymes.
We next examined whether upregulated expression of membrane-trafficking regulators and lysosomal 
enzymes are required for the enhanced bactericidal activity seen in BLP-tolerised macrophages by silencing 
Rab10 expression. Transfection of murine BMMs with Rab10 specific small interfering RNA (siRNA), siRab10-1 
and siRab10-2, efficiently knocked down Rab10 expression at both the mRNA (Fig. 3A) and the protein (Fig. 3B) 
Figure 1. Accelerated phagosome maturation and enhanced bactericidal activity in BLP-tolerised 
macrophages. (A,B) Uptake (A) and phagocytosis (B) of S. aureus and S. typhimurium (S. typhi) at 30 min by 
naive and BLP-tolerised macrophages were expressed as mean channel fluorescence (MCF) per cell.  
(C) Intracellular killing of ingested S. aureus and S. typhi at 60 min by naive and BLP-tolerised macrophages.  
(D,E) Phagosomal pH in naive and BLP-tolerised macrophages after chased with fluorescent probe-coupled S. aureus  
(D) or S. typhi (E). (F) Phagolysosome fusion in phagosomes from naive and BLP-tolerised macrophages 
after chased with S. aureus or S. typhi was expressed as mean fluorescence intensity (MFI). (G,H) Naive and 
BLP-tolerised macrophages were loaded with LysoTraker red and further incubated with S. aureus-FITC 
(G) or E. coli-FITC (H). Cell nuclei were stained with DAPI. Fluorescent micrographs were taken at 60 min 
after incubation with either S. aureus-FITC or E. coli-FITC. Scale bar = 10 μ m. All Data are mean ± SD. Data 
in (A,B,D,E and F) are from four to six independent experiments in duplicate and data in C are from five 
independent experiments in triplicate. *p < 0.05, **p < 0.01 compared with naive macrophages.
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levels compared with BMMs transfected with scrambled siRNA (scrRNA). Knockdown of Rab10 with siRab10-2 
did not affect BLP-tolerised BMMs to ingest S. typhimurium (Fig. 3C), but markedly impaired intracellular killing 
of the ingested S. typhimurium by BLP-tolerised BMMs (p < 0.05, p < 0.01 versus BLP-tolerised BMMs trans-
fected with scrambled siRNA) (Fig. 3D), suggesting that upregulated expression of membrane-trafficking reg-
ulators and lysosomal enzymes contributes to an enhanced bactericidal activity in BLP-tolerised macrophages.
Bacterial stimulation leads to activation of the NF-κB pathway in BLP-tolerised mac-
rophages. Our previous work has shown that BLP-induced self-tolerance and cross-tolerance to LPS are 
associated with the suppressed TLR2 signalling at both the upstream and downstream pathways22–24. We there-
fore attempted to examine the influence of bacterial infection on TLR2-mediated intracellular signal transduc-
tion pathways in naive and BLP-tolerised macrophages. As shown in Fig. 4A, stimulation of naive BMMs with 
S. aureus or S. typhimurium resulted in substantial activations in the downstream pathways of TLR2 signalling 
including phosphorylation of MAPK p38, the inhibitor of κ Bα (Iκ Bα ), and NF-κ B p65, whereas an almost com-
plete suppression of MAPK p38 phosphorylation was observed in BLP-tolerised BMMs after stimulation with 
S. aureus or S. typhimurium. Surprisingly, BLP-tolerised BMMs showed strong activation of the NF-κ B pathway 
with substantially enhanced phosphorylation of Iκ Bα at Ser32 and NF-κ B p65 at Ser586 in response to either 
S. aureus or S. typhimurium stimulation (Fig. 4A), which is largely different from our previous findings22,23 where 
BLP-tolerised monocytes/macrophages exhibited suppressed Iκ Bα phosphorylation and reduced NF-κ B-DNA 
binding activity in response to a second BLP or LPS stimulation. Expression of the upstream pathways of TLR2 
signalling including TLR2, MyD88, and IRAK-1 in BLP-tolerised BMMs after stimulation with S. aureus or 
S. typhimurium (Fig. 4B) was similar to those seen previously in BLP-tolerised monocytes/macrophages after 
stimulation with BLP or LPS22–24.
To further confirm bacterial stimulation-induced NF-κ B activation in BLP-tolerised macrophages, we mon-
itored the nuclear translocation of NF-κ B p65 upon S. typhimurium infection in both naive and BLP-tolerised 
macrophages. Before bacterial challenge, almost all of the detected p65 staining was located in the cytoplasm of 
naive BMMs, whereas some positive staining for p65 was also observed in the nucleus of BLP-tolerised BMMs 
(Fig. 4C) (Supplementary Fig. S1). In response to S. typhimurium infection, substantially enhanced translocation 
of p65 from the cytoplasm into the nucleus was evident not only in naive macrophages but also in BLP-tolerised 
BMMs (Fig. 4C,D) (Supplementary Fig. S1). Together, these results indicate that bacterial stimulation, in contrast 
to a second BLP or LPS stimulation, activates the NF-κ B pathway in BLP-tolerised macrophages.
Activation of the NF-κB pathway is responsible for accelerated phagosome maturation 
and enhanced bactericidal activity in BLP-tolerised macrophages. To ascertain whether 
bacteria-induced activation of the NF-κ B pathway is associated with accelerated phagosome maturation and 
Figure 2. Up-regulated expression of membrane-trafficking regulators and lysosomal enzymes in BLP-
tolerised macrophages. (A) Expression of Acp2, Acp5, Rab10, Rab 20, Rabgef1, Camp, and Ctsc mRNA in 
naive and BLP-tolerised BMMs was assessed by quantitative real-time RT-PCR. Data are mean ± SD from at 
least three independent experiments and each experiment was conducted in duplicate. *p < 0.05, **p < 0.01 
compared with naive BMMs. (B) Expression of Rab10 and Acp5 protein in naive and BLP-tolerised BMMs 
at the indicated time points after S. typhimurium (S. typhi) stimulation was assessed by Western blot analysis. 
Results shown represent one experiment from a total of three separate experiments.
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enhanced bactericidal activity characterised in BLP-tolerised macrophages, we abrogated the NF-κ B pathway 
using two specific NF-κ B inhibitors, SN50 and SC-514. Pretreatment with either SN50 or SC-514 significantly 
reduced intracellular killing of S. aureus (Fig. 5A) and S. typhimurium (Fig. 5B) in naive macrophages (p < 0.05 
versus naive macrophages pretreated with culture medium); however, a much stronger impairment in bactericidal 
activity with substantially diminished intracellular killing of both S. aureus (Fig. 5A) and S. typhimurium (Fig. 5B) 
was observed in SN50-pretreated or SC-514-pretreated, BLP-tolerised macrophages (p < 0.05, p < 0.01 versus 
BLP-tolerised macrophages pretreated with culture medium). Furthermore, inhibition of NF-κ B activation with 
either SN50 or SC-514 markedly delayed phagolysosome fusion in BLP-tolerised macrophages after ingestion of 
E. coli compared with BLP-tolerised macrophages pretreated with culture medium (Fig. 5C).
As upregulation of membrane-trafficking regulators and lysosomal enzymes contributes to an enhanced bac-
tericidal activity in BLP-tolerised macrophages, we next examined whether inhibition of NF-κ B activation affects 
Acp5 and Rab10 expression at the mRNA and protein levels. Pretreatment of naive BMMs with SC-514 signifi-
cantly attenuated mRNA expression of Acp5, but not Rab10, at 60 min after S. typhimurium infection (p < 0.01 
versus naive BMMs pretreated with culture medium), whereas SC-514 pretreatment substantially abrogated 
S. typhimurium-induced mRNA expression of both Acp5 and Rab10 in BLP-tolerised BMMs (p < 0.01 versus 
BLP-tolerised BMMs pretreated with culture medium) (Fig. 6A). Notably, pretreatment with SC-514 significantly 
attenuated S. typhimurium-enhanced protein expression of Acp5 and Rab10 in BLP-tolerised BMMs (p < 0.05 
versus BLP-tolerised BMMs pretreated with culture medium) (Fig. 6B,C), but not in naive BMMs (Fig. 6B,C). 
Collectively, these results indicate that activation of the NF-κ B pathway by bacterial infection is the prerequisite 
for the observed augmentation of bactericidal activity in BLP-tolerised macrophages, partly via upregulation of 
membrane-trafficking regulators and lysosomal enzymes.
Bacteria-activated NF-κB pathway in BLP-tolerised macrophages is dependent on NOD1 
and NOD2. NOD1 and NOD2 are two members of the nucleotide binding and oligomerization domain 
(NOD)-like receptor (NLR) family, located in the cytoplasm, and belong to the intracellular PRRs28–30. 
Engagement of NOD1 and/or NOD2 with bacterial ligands predominantly leads to activation of their down-
stream NF-κ B pathway31,32. Therefore, we asked whether NOD1 and NOD2 are involved in bacteria-activated 
NF-κ B pathway in BLP-tolerised macrophages, thus facilitating an enhanced bactericidal activity. We first 
assessed NOD1 and NOD2 expression in naive and BLP-tolerised macrophages before and after bacterial chal-
lenge. As shown in Fig. 7A,B, BLP-tolerised BMMs exhibited significantly higher mRNA expression of both 
NOD1 and NOD2 than naive BMMs before bacterial challenge (p < 0.01). Substantially increases in mRNA levels 
Figure 3. Silencing Rab10 diminishes BLP-tolerised macrophage-induced intracellular bacterial killing. 
(A,B) Murine BMMs were transfected with two Rab10 specific siRNA, siRab10-1 and siRab10-2, or its 
scrambled siRNA (scrRNA). Expression of Rab10 mRNA (A) and protein (B) was assessed by quantitative real-
time RT-PCR and Western blot analysis 24 hrs after transfection. (C,D) Phagocytosis of S. typhimurium (C) and 
intracellular killing of the ingested S. typhimurium (D) by BLP-tolerised BMMs transfected with either scrRNA 
or siRab10-2. Data are mean ± SD from four to six independent experiments in duplicate or triplicate. *p < 0.05, 
**p < 0.01 compared with BLP-tolerised BMMs transfected with scrRNA.
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of NOD1 (Fig. 7A) and NOD2 (Fig. 7B) were seen in both naive and BLP-tolerised BMMs in response to S. 
aureus or S. typhimurium infection; however, much higher mRNA expression of NOD1 and NOD2 was seen in 
BLP-tolerised BMMs compared with naive BMMs (p < 0.05, p < 0.01) (Fig. 7A,B). We further assessed protein 
expression of NOD1 and NOD2 in response to S. typhimurium infection in naive and BLP-tolerised BMMs. 
Surprisingly, in contrast to the enhanced mRNA expression, no obvious increases in protein expression of both 
NOD1 and NOD2 were observed in BLP-tolerised BMMs after S. typhimurium stimulation compared with naive 
BMMs (Fig. 7C,D).
We next examined whether knockdown of NOD1 and NOD2 with their specific siRNA affects 
bacteria-stimulated NF-κ B activation in BLP-tolerised macrophages. Transfection of murine BMMs with the 
NOD1 specific siRNA (siNOD1) or NOD2 specific siRNA (siNOD2) efficiently knocked down NOD1 and NOD2 
protein expression compared with BMMs transfected with their scrRNA) (Fig. 8A). Of note, markedly increased 
nuclear translocation of cytoplasmic NF-κ B p65 was seen in BLP-tolerised BMMs transfected with scrRNA at 
30 and 60 min after S. typhimurium infection, whereas doubly knocking-down NOD1 and NOD2 substantially 
reduced S. typhimurium-stimulated translocation of p65 from the cytoplasm into the nucleus in BLP-tolerised 
BMMs (p < 0.05 versus BLP-tolerised BMMs transfected with scrRNA) (Fig. 8B,C) (Supplementary Fig. S2), 
suggesting that blocking NOD1 and NOD2 inhibits bacteria-induced NF-κ B activation in BLP-tolerised 
macrophages.
We further determined whether knockdown of either NOD1 or NOD2 influences membrane-trafficking regu-
lator and lysosomal enzyme Acp5 and Rab10 expression in BLP-tolerised macrophages. S. typhimurium infection 
Figure 4. Bacterial stimulation-induced activation of the NF-κB pathway in BLP-tolerised macrophages. 
Naive and BLP-tolerised BMMs were stimulated with S. aureus or S. typhimurium (S. typhi) for the indicated 
time periods. (A,B) Cytoplasmic proteins were extracted and subjected to immunoblotting for detection of 
total and phosphorylated p38 (P-p38), total and phosphorylated Iκ Bα (P-Iκ Bα ), total and phosphorylated p65 
(P-p65), TLR2, MyD88, and IRAK-1. Results shown represent one experiment from a total of three separate 
experiments. (C,D) Confocal images were taken at the indicated time points after naive and BLP-tolerised 
BMMs were subjected to S. typhimurium infection by immunofluorescent staining with the anti-p65 Ab and 
Alexa Flour 594-conjugated secondary Ab (C), and nuclear translocation of p65 was quantitatively analysed and 
expressed as mean fluorescence intensity (MFI) ratio (D). Results shown represent one experiment from a total 
of three separate experiments. Cell nuclei were stained with DAPI. Scale bar = 10 μ m.
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resulted in markedly enhanced mRNA expression of Rab10 and Acp5 in BLP-tolerised BMMs (Fig. 8D,E). 
Knocking-down NOD1 in BLP-tolerised BMMs strongly inhibited S. typhimurium-induced upregulation of 
Rab10 mRNA, but not of Acp5 mRNA (p < 0.01 versus BLP-tolerised BMMs transfected with scrRNA) (Fig. 8D), 
whereas knocking-down NOD2 in BLP-tolerised macrophages markedly suppressed S. typhimurium-induced 
mRNA expression of both Acp5 and Rab10 (p < 0.05, p < 0.01 versus BLP-tolerised BMMs transfected with scr-
RNA) (Fig. 8E). Moreover, Knocking-down either NOD1 (Fig. 8F) or NOD2 (Fig. 8G) resulted in a substantial 
attenuation in protein expression of both Acp5 and Rab10. Critically, knockdown of both NOD1 and NOD2 in 
BLP-tolerised BMMs strongly impaired bactericidal activity with significantly diminished intracellular killing of 
the ingested S. typhimurium (p < 0.05, p < 0.01 versus BLP-tolerised BMMs transfected with scrRNA) (Fig. 8H). 
These results indicate that both NOD1 and NOD2 contribute primarily to bacteria-stimulated activation of the 
NF-κ B pathway, upregulation of membrane-trafficking regulators and lysosomal enzymes, and subsequently aug-
mented bactericidal activity seen in BLP-tolerised macrophages.
Discussion
BLP tolerance-afforded protection against microbial sepsis is closely associated with BLP-induced reprogram-
ming in innate phagocytes characterised by hyporesponsiveness in producing proinflammatory cytokines and 
simultaneously, an augmented antimicrobial activity16,20,21. Although the signal transduction pathway underlying 
BLP tolerance-attenuated inflammatory responses has been well described22–24, mechanism(s) involved in BLP 
tolerance-enhanced antimicrobial activity in phagocytes is undetermined. In the current study, we demonstrated 
that BLP-tolerised macrophages exhibited accelerated phagosome maturation and enhanced bactericidal activity 
in response to bacterial infection. Notably, stimulation of BLP-tolerised macrophages with bacteria led to a strong 
activation of the NF-κ B pathway. Importantly, activation of the NF-κ B pathway appeared to be a prerequisite for 
BLP tolerance-induced augmentation of antimicrobial activity and predominantly dependent on both NOD1 
and NOD2.
Figure 5. Inhibition of NF-κB activation impairs phagosome maturation and bactericidal activity in BLP-
tolerised macrophages. (A,B) Naive and BLP-tolerised macrophages pretreated with two NF-κ B inhibitors 
SN50 (25, 50 μ g/ml), SC-514 (25, 50 nM) or culture medium (CM) for 60 min were stimulated with S. aureus 
or S. typhimurium to assess intracellular killing of the ingested S. aureus (A) and S. typhimurium (B). Data are 
mean ± SD from five independent experiments in triplicate. *p < 0.05, **p < 0.01 compared with naive or BLP-
tolerised macrophages pretreated with CM. (C) Naive and BLP-tolerised macrophages pretreated with SN50 
(50 μ g/ml) or SC514 (50 nM) were loaded with LysoTraker red and further incubated with E. coli-FITC. Cell 
nuclei were stained with DAPI. Fluorescent micrographs were taken at 60 min after incubation with E. coli-
FITC. Scale bar = 10 μ m.
www.nature.com/scientificreports/
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Figure 6. Inhibition of NF-κB activation attenuates Acp5 and Rab10 expression in BLP-tolerised 
macrophages. Naive and BLP-tolerised BMMs pretreated with the NF-κ B inhibitors SC-514 (50 nM) or culture 
medium (CM) for 60 min were stimulated with S. typhimurium (S. typhi) for the indicated time periods.  
(A) Expression of Acp5 and Rab10 mRNA was assessed by quantitative real-time RT-PCR. Data are mean ± SD 
from four to five independent experiments and each experiment was conducted in duplicate. **p < 0.01 
compared with naive or BLP-tolerised BMMs pretreated with CM. (B) Expression of Acp5 and Rab10 protein 
was assessed by Western blot analysis. Results shown represent one experiment from a total of three separate 
experiments. (C) The relative intensity of Acp5 and Rab10 was analysed by densitometry. *p < 0.05 compared 
with BLP-tolerised BMMs pretreated with CM.
www.nature.com/scientificreports/
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We first examined whether isolated murine macrophages after induction of BLP tolerance developed an 
enhanced antimicrobial activity in response to bacterial infection. Significantly enhanced uptake and phago-
cytosis of both gram-positive S. aureus and gram-negative S. typhimurium were observed in BLP-tolerised 
macrophages compared with naive macrophages. The antimicrobial response of innate immunity is initiated 
by the receptor-associated recognition of the invading microbial pathogens and subsequently, these pathogens 
are engulfed by innate phagocytes and killed within the phagocyte through a process of phagosome/lysosome 
fusion26,33,34. Thus, phagosome maturation after ingestion of microbial pathogens, characterised by phagosomal 
acidification and phagolysosome fusion, is a critical step in the killing and degradation of the internalised path-
ogens. We next asked whether induction of BLP tolerance in macrophages affects phagosome maturation upon 
bacterial ingestion, thus facilitating intracellular killing of the internalised pathogens. By measuring both phago-
somal acidification and phagolysosome fusion, we confirmed that BLP-tolerised macrophages were characterised 
with accelerated phagosome maturation. Consequently, substantially increased intracellular killing of the ingested 
S. aureus and S. typhimurium was evident in BLP-tolerised macrophages compared with naive macrophages.
Activation and/or upregulation of membrane-trafficking regulators and lysosomal enzymes in innate phago-
cytes during the process of bacterial phagocytosis are critical events for phagosome formation, phagosome/lys-
osome fusion, and subsequent efficient killing of the internalized pathogens25–27. For instance, perturbation of 
Rab5 or Rab7 activation impairs late phagosome and phagolysosome formation35, and blocks phagosomal acidifi-
cation and phagosome/lysosome fusion36,37. Moreover, it has been shown that the lysosome-associated membrane 
protein (LAMP) is essential not only for recruitment of Rab7 during phagolysosome fusion but also for the acqui-
sition of bactericidal activity in the phagosome38,39. Therefore, we examined whether an enhanced bactericidal 
activity observed in BLP-tolerised macrophages is linked to the upregulated membrane-trafficking regulators 
and lysosomal enzymes. RT2 profiler PCR arrays and quantitative real-time RT-PCR revealed that induction 
of BLP tolerance in murine BMMs upregulated gene expression of membrane-trafficking regulators and lyso-
somal enzymes. Western blot analysis demonstrated that expression of Rab10 and Acp5 proteins was further 
enhanced in response to bacterial stimulation in BLP-tolerised BMMs. Critically, knockdown of Rab10 dramat-
ically impaired BLP-tolerised BMM-associated intracellular killing of the ingested microbial pathogens, indi-
cating the involvement of membrane-trafficking regulators and lysosomal enzymes in BLP tolerance-enhanced 
bactericidal activity.
Our previous work has demonstrated that BLP-induced tolerance in monocytes/macrophages is associated 
with the suppressed TLR2 signalling at both the upstream and downstream pathways, with diminished expression 
of TLR2 and IRAK-1, reduced formation of MyD88-IRAK immunocomplex, and inhibited activation of both 
NF-κ B and MAPKs in response to a second BLP or LPS stimulation22–24. However, it is unclear the impact of bac-
terial infection on TLR2-mediated signal transduction pathways in BLP-tolerised macrophages. We found that 
expression of TLR2, MyD88, and IRAK-1, the upstream components of TLR2 signalling, and phosphorylation of 
MAPK p38, one of the downstream pathways of TLR2 signalling, in BLP-tolerised BMMs after stimulation with 
S. aureus or S typhimurium were similar to those seen in BLP-tolerised monocytes/macrophages after stimula-
tion with BLP or LPS22–24. By contrast, phosphorylation of Iκ Bα and NF-κ B p65, and translocation of p65 from 
Figure 7. Enhanced mRNA expression of NOD1 and NOD2 in BLP-tolerised macrophages in response to 
bacterial stimulation. (A,B) Naive and BLP-tolerised BMMs were stimulated with S. aureus or S. typhimurium 
for the indicated time periods. Expression of NOD1 and NOD2 mRNA was assessed by quantitative real-time 
RT-PCR. Data are mean ± SD from four to five independent experiments and each experiment was conducted 
in duplicate. *p < 0.05, **p < 0.01 compared with naive BMMs. (C,D) Expression of NOD1 and NOD2 protein 
in naive and BLP-tolerised BMMs after stimulation with S. typhimurium (S. typhi) for the indicated time periods 
was assessed by Western blot analysis. Results shown represent one experiment from a total of three separate 
experiments.
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Figure 8. Both NOD1 and NOD2 are involved in bacteria-stimulated activation of the NF-κB pathway in 
BLP-tolerised macrophages. (A) Murine BMMs were transfected with the NOD1 specific siRNA (siNOD1), 
NOD2 specific siRNA (siNOD2), or their scrambled siRNA (scrRNA). Expression of NOD1 and NOD2 protein 
was assessed by Western blot analysis 24 hrs after transfection. (B,C) BLP-tolerised BMMs transfected with 
siNOD1/NOD2 or scrRNA were stimulated with S. typhimurium for the indicated time periods. Confocal 
images were taken after cells were stained with the anti-p65 Ab and Alexa Flour 594-conjugated secondary Ab 
(B), and nuclear translocation of p65 was quantitatively analysed and expressed as mean fluorescence intensity 
(MFI) ratio (C). Results shown represent one experiment from a total of three separate experiments. Cell nuclei 
were stained with DAPI. Scale bar = 10 μ m. (D–G) BLP-tolerised BMMs transfected with siNOD1, siNOD2, 
or their scrRNA were stimulated with S. typhimurium (S. typhi) for the indicated time periods. Expression of 
Acp5 and Rab10 mRNA (D,E) was assessed by quantitative real-time RT-PCR. Expression of Acp5 and Rab10 
protein (F,G) was assessed by Western blot analysis. Results shown represent one experiment from a total of 
three separate experiments. (H) Intracellular killing of the ingested S. typhimurium by BLP-tolerised BMMs 
transfected with either siNOD1/NOD2 or scrRNA. All data are mean ± SD from four to six independent 
experiments in duplicate or triplicate. *p < 0.05, **p < 0.01 compared with BLP-tolerised BMMs transfected 
with scrRNA.
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the cytoplasm into the nucleus in BLP-tolerised BMMs were substantially enhanced in response to S. aureus or 
S. typhimurium stimulation, demonstrating that bacterial stimulation activates the NF-κ B pathway, a more pre-
dominant downstream pathway of TLR2 signalling, in BLP-tolerised macrophages. NF-κ B is a central regulator 
for both innate and adaptive immune functions40,41, and NF-κ B activation has been shown to promote the antimi-
crobial response by facilitating bacterial phagocytosis and killing in macrophages42,43. Therefore, we hypothesised 
that activation of the NF-κ B pathway by bacterial infection is responsible for an augmented antimicrobial activ-
ity characterised in BLP-tolerised macrophages. To test this, we abrogated the NF-κ B pathway with its specific 
inhibitors. As expected, ablation of NF-κ B activation substantially blocked phagolysosome fusion and impaired 
intracellular killing of both the ingested S. aureus and S. typhimurium in BLP-tolerised macrophages. Moreover, 
inhibition of NF-κ B in BLP-tolerised BMMs strongly attenuated S. typhimurium-induced overexpression of Acp5 
and Rab10, two membrane-trafficking regulators and lysosomal enzymes linked to BLP tolerance-enhanced bac-
tericidal activity.
The remaining question is that by which signal pathway and/or molecular event bacterial stimulation activates 
the NF-κ B pathway in BLP-tolerised macrophages. The membrane-bound TLRs and the cytoplasmic NLRs are 
two major classes of PRRs that are primarily responsible for recognition of PAMPs of bacterial origin11,13,28,44. 
Similar to TLR signalling, upon recognition of bacterial ligands both NOD1 and NOD2 initiate the targeted gene 
transcription by activating the NF-κ B transcription factor signalling pathway via recruitment of the adaptor pro-
teins RICK and caspase recruitment domain 9 (CARD9)31,32,45. Therefore, we speculated that bacteria-stimulated 
activation of the NF-κ B pathway in BLP-tolerised macrophages is via NOD1 and/or NOD2 signalling. Although 
we found upregulated mRNA expression, we did not detect enhanced protein levels of NOD1 and NOD2 in 
BLP-tolerised BMMs after bacterial infection. However, knockdown of both NOD1 and NOD2 impaired 
bacteria-induced activation of the NF-κ B pathway in BLP-tolerised BMMs, as evidenced by significantly reduced 
nuclear translocation of p65 in response to bacterial infection. Furthermore, silencing NOD1 or NOD2 in 
BLP-tolerised BMMs markedly suppressed bacteria-stimulated upregulation of membrane-trafficking regulators 
and lysosomal enzymes Acp5 and Rab10. Finally, knockdown of both NOD1 and NOD2 substantially diminished 
intracellular killing of the ingested S. typhimurium by BLP-tolerised BMMs. These results highlight the involve-
ment of both NOD1 and NOD2 signalling in bacteria-induced activation of the NF-κ B pathway and subsequently 
enhanced bactericidal activity in BLP-tolerised macrophages.
In conclusion, we demonstrate that in response to bacterial infection BLP-tolerised macrophages are charac-
terised with accelerated phagosome maturation and enhanced bactericidal activity. Furthermore, bacterial stim-
ulation leads to a strong activation of the NF-κ B pathway in BLP-tolerised macrophages via both NOD1 and 
NOD2 signalling. More importantly, Bacteria-stimulated NF-κ B activation is critical for BLP tolerance-induced 
augmentation of antimicrobial activity. These findings suggest that modulation of the TLR2 signalling in innate 
phagocytes to augment the bactericidal activity may represent a potential therapeutic strategy during microbial 
infection.
Methods
Reagents and antibodies. The TLR2 agonist BLP, a synthetic bacterial lipopeptide (Pam3Cys-Ser-
Lys4-OH), was purchased from EMC Microcollections (Tubingen, Germany). Abs that recognize TLR2, MyD88, 
and IRAK1 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and Abcam (Cambridge, MA, 
USA), respectively. Abs that recognize p38, phospho-p38, Iκ Bα , phosphor-Iκ Bα at Ser32, p65, phosphor-p65 at 
Ser276 or at Ser586, Acp5, Rab10, NOD1, and NOD2 were purchased from Santa Cruz Biotechnology and Cell 
Signalling Technology (Beverly, MA, USA), respectively. siRNA specifically targeting NOD1, NOD2, Rab10, and 
their scrRNA were obtained from GenePharma (Shanghai, China). The NF-κ B inhibitors SN50 and SC-514 were 
purchased from Merck Millipore (Billerica, MA, USA). All culture medium and reagents used for cell cultures 
were purchased from Invitrogen Life Technologies (Paisley, Scotland, U.K.). All other chemicals, unless indicated, 
were from Sigma-Aldrich (St. Louis, MO, USA).
Mice, murine macrophage isolation and cultures. Pyrogen-free, 8- to 10-wk-old C57BL/6 mice were 
purchased from Harlan (Oxon, U.K.). Mice were housed in barrier cages under controlled environmental condi-
tions (12/12 hrs light/dark cycle, 55 ± 5% humidity, 23 °C) in the University Biological Services Unit, University 
College Cork. All animal procedures were performed in the University Biological Services Unit under a license 
from the Department of Health (Republic of Ireland) and with ethical approval granted from the University 
College Cork Ethics Committee. The methods applied in this study were carried out in accordance with the 
approved guidelines.
Peritoneal macrophages were collected from C57BL/6 mice by peritoneal lavage and incubated with 
DMEM containing 10% heat-inactivated FCS for 90 min to remove non-adherent cells, as described previ-
ously46. BMMs were isolated from the femurs and tibias of C57BL/6 mice and cultured in DMEM containing 
20% heat-inactivated FCS, penicillin (100 units/ml), streptomycin sulfate (100 μ g/ml), and supplemented with 
10 ng/ml of recombinant mouse macrophage-CSF (R&D Systems, Minneapolis, MN, USA) for 7 days at 37 °C 
in a humidified 5% CO2 atmosphere, as described previously46. The purity of both peritoneal macrophages and 
BMMs was > 95%, as confirmed by FAC Scan analysis of the positive F4/80 Ag staining with a rat anti-mouse 
F4/80 Ab (Serotec, Oxford, U.K.).
Induction of BLP tolerance. For induction of BLP tolerance, isolated peritoneal macrophages or BMMs 
were pretreated with culture medium (naive) or BLP at 100 ng/ml (BLP-tolerised) for 24 hrs before bacterial chal-
lenge, as described previously22–24.
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Bacteria and bacterial uptake, ingestion, and killing. Gram-positive S. aureus and gram-negative 
S. typhimurium were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA) and the 
National University of Ireland Culture Collection, respectively. Bacteria were cultured at 37 °C in trypticase soy 
broth (Merck, Darmstadt, Germany), harvested at the mid-logarithmic growth phase, washed twice, and resus-
pended in PBS for in vitro use. The concentration of resuspended bacteria was determined and adjusted spectro-
photometrically at 550 nm.
Bacterial uptake, phagocytosis, and intracellular bacterial killing were determined as described previ-
ously21,47. Briefly, S. aureus and S. typhimurium were heat-killed at 95 °C for 20 min and labelled with 0.1% FITC 
(Sigma-Aldrich). Isolated peritoneal macrophages or BMMs were incubated with heat-killed, FITC-labelled 
S. aureus or S. typhimurium at a ratio of 1:20 (macrophage:bacteria) at 37 °C for various time periods. Bacterial 
uptake was assessed by FACScan analysis and bacterial ingestion was further determined after the external flu-
orescence of the bound, but non-ingested, bacteria was quenched with 0.025% crystal violet (Sigma-Aldrich). 
Intracellular bacterial killing was determined by incubation of macrophages with live S. aureus or S. typhimu-
rium (macrophage:bacteria = 1:20) at 37 °C for various time periods in the presence or absence of cytochalasin B 
(5 μ g/ml) (Sigma-Aldrich). After macrophages were lysed, total and extracellular bacterial killing were deter-
mined by incubation of serial 10-fold dilutions of the lysates on tryptone soy agar (Merck) plates at 37 °C for 
24 hrs. Intracellular bacterial killing was calculated according to the total and extracellular bacterial killing.
Measurement of phagosomal pH. Phagosome luminal pH was assessed as described pre-
viously47,48. Briefly, heat-killed S. aureus and S. typhimurium were doubly labelled with 5 μ g/ml 
carboxyfluorescein-SE (a pH-sensitive fluorescent probe) (Molecular Probes, Eugene, OR, USA) and 10 μ g/ml 
carboxytetramethylrhodamine-SE (a pH-insensitive fluorescent probe) (Molecular Probes). Isolated peritoneal 
macrophages were pulsed with the labelled bacteria (macrophage:bacteria = 1:20) for 20 min, and then chased 
at 37 °C for the indicated time periods. Macrophage-based mean fluorescence intensity (MFI) of fluorescein on 
FL1 and rhodamine on FL2 were simultaneously detected by FACScan analysis using CellQuest software (BD 
Biosciences, San Jose, CA, USA). Phagosomal pH was calculated according to the ratio of fluorescein:rhodamine 
fluorescence using a calibration curve.
Assessment of phagosome maturation in a cell-free organelle system. Isolated peritoneal mac-
rophages were labelled with a red fluorescent cell membrane linker PKH26 (20 μ M) (Sigma-Aldrich) for subse-
quent phagosome recognition, as described previously47,49. PKH26-labelled macrophages were pulsed and chased 
with heat-killed S. aureus or S. typhimurium (macrophage:bacteria = 1:20) at 37 °C for the indicated time periods. 
Cells were lysed in a hypotonic buffer, and phagosomes were prepared by centrifugation. The isolated phago-
somes were permeabilised with 0.2% saponin (Sigma-Aldrich) and stained with FITC-conjugated anti-LAMP-1 
mAb (Abcam) that specially recognizes late endosomes/lysosomes, or FITC-conjugated isotype-matched mAb 
(Abcam) as the negative control. The green MFI of LAMP-1 on the positive red fluorescent events (phagosomes 
that have ingested bacteria), representing phagolysosome fusion and/or phagosome maturation, were quantita-
tively assessed by FACScan analysis using CellQuest software (BD Biosciences).
Phagosome/lysosome fusion assay. Isolated peritoneal macrophages were plated into 8-well chamber 
slides (Lab-Tek™ , Nunc, Rochester, NY, USA) at 1 × 105 cells/well. After rested in RPMI1640 containing 1% FCS 
for 6 hrs, cells were loaded with LysoTracker red (50 nM) (Molecular Probes) at 37 °C for 30 min, and further 
incubated with S. aureus or E. coli conjugated with FITC (Molecular Probes) (macrophage:bacteria = 1:20) for 
various time periods. LysoTracker red was replenished every hour of incubation. After each time point, slides 
were vigorously washed 5 times in cold PBS and fixed in 2% paraformaldehyde (Sigma-Aldrich). Cell nuclei were 
stained with DAPI (Molecular Probes). Slides were mounted with coverslips and examined under a fluorescent 
Olympus BX61-TRF microscope (Olympus, Tokyo, Japan). Fluorescent images were acquired using the cell imag-
ing software for life sciences microscopy (Olympus soft imaging solutions, Munster, Germany). Unfused pha-
gosomes containing FITC-bacteria and lysosomes labelled with LysoTracker red were stained in green and red, 
respectively, whereas phagosomes containing FITC-bacteria after fused with LysoTracker red-labelled lysosomes 
were stained in yellow due to the coexistence of the two fluorochromes.
Small interfering RNA transfection. Naive and BLP-tolerised BMMs were transfected with NOD1 and 
NOD2 specific siRNA or Rab10 specific siRNA (siRab10-1 and siRab10-2) by electroporation using a NEPA21 
super electroporator (Nepagene, Chiba, Japan), and their scrRNA were used as the non-silencing control. Total 
RNA was extracted 24 hrs after transfection and the efficiency of interference was analyzed by quantitative 
real-time RT-PCR.
RT2 profiler PCR arrays. RT2 profiler PCR arrays (Qiagen, Valencia, CA, USA) were used to profile gene 
expression of phagosome maturation-associated membrane-trafficking regulators and lysosomal enzymes. Total 
RNA was extracted from naïve and BLP-tolerised BMMs using an RNeasy kit (Qiagen) and the single strand 
cDNA from 2–3 μ g total RNA was synthesised using an RT2 first strand kit (Qiagen). Real-time PCR was per-
formed according to the user manual of RT2 profiler PCR array system. Thermal cycling and fluorescent detec-
tion were performed on the ABI 7900HT 384-well block detection system (Applied Biosystems, Foster City, CA, 
USA). All data were analysed using Excel-based RT2 profiler PCR array analysis templates (Qiagen).
Quantitative real-time RT-PCR. Total RNA was extracted from naive and BLP-tolerised BMMs at the 
indicated time periods using TRIzol (Invitrogen) and reverse-transcribed into cDNA using the ReverTra Ace 
qPCR RT kit (Toyobo, Osaka, Japan). Amplification of cDNA was conducted using an ABI 7500 thermal cycler 
(Thermo Fisher Scientific, Waltham, MA, USA). The target gene mRNA expression was analyzed with FastStart 
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universal SYBR green master (Roche Life Science, Indianapolis, IN, USA) and normalised with the housekeeping 
gene β -actin. The gene-specific primers used in this study were listed in Table 1.
Western blot analysis. Following incubation with heat-killed S. aureus or S. typhimurium, naive and 
BLP-tolerised BMMs were collected at the indicated time periods, washed with ice-cold PBS, and lysed on ice 
in cell lysis buffer (Cell Signalling Technology), supplemented with 1 mM phenylmethylsulfonyl fluoride and 
protease inhibitor cocktail (Roche Life Science). The resultant lysates were centrifuged and supernatants contain-
ing the cytoplasmic proteins were collected. Protein concentration was determined using a micro BCA protein 
assay (Pierce, Rockford, IL, USA). Equal amounts of protein extracts were separated on SDS-polyacrylamide 
gels and transferred to polyvinylidene difluoride (PVDF) membranes (Schleicher & Schuell, Dassel, Germany). 
The membrane was blocked for 1 hr at room temperature with PBS containing 0.05% Tween-20 and 5% nonfat 
milk, and probed overnight at 4 °C with primary Abs. Blots were then incubated with appropriate horseradish 
peroxidase-conjugated secondary Abs (Dako, Cambridge, U.K.) at room temperature for 1 hr, developed with 
SuperSignal chemiluminescent substrate (Pierce), and captured with LAS-3000 imaging system (Fujifilm, Tokyo, 
Japan).
Immunocytochemistry. Naive and BLP-tolerised BMMs were plated into 24-well chamber slides 
(Lab-Tek™ ) at 1 × 105 cells/well. After rested in RPMI1640 containing 1% FCS for 6 hrs, cells were incubated 
with heat-killed S. aureus or S. typhimurium (macrophage:bacteria = 1:20) for the indicated time periods. After 
each time point, cells were washed 5 times in cold PBS, fixed in 2% paraformaldehyde, and permeabilised in 
0.1% Triton X-100 for 10 min and 0.1% NaBH4 for 5 min. After blocked with PBS containing 0.05% Tween-20 
and 3% BSA for 2 hrs, cells were incubated with the primary anti-p65 Ab overnight at 4 °C and further incu-
bated with the Alexa Flour 594-conjugated secondary Ab (Molecular Probes) at room temperature for 1 hr. Cell 
nuclei were stained with DAPI (Molecular Probes). Slides were mounted with coverslips and images were taken 
under a LSM710 confocal laser scanning microscope (Zeiss, Oberkochen, Germany). The mean fluorescent inten-
sity (MFI) of NF-κ B p65 nuclear translocation was quantitatively measured as described previously50. Briefly, 
randomised 30 cells from at least five separate high-power fields per staining were selected for analysis. Image 
analysis of nuclear and cytoplasmic p65 fluorescent intensities was performed using the ImageJ software. The 
MFI of p65 nuclear translocation was calculated according to the ratio of nuclear to cytoplasmic p65 fluorescent 
intensities.
Statistical analysis. All data are expressed as the mean ± SD. Statistical analysis was performed using 
Student’s t test or ANOVA, with GraphPad software version 5.01 (Prism, La Jolla, CA, USA). Differences were 
judged to be statistically significant when the p value was less than 0.05.
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